KELLI STRICKLAND: Open Payments
NPI 1831750926 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,006 in 154 payments from 19 companies in 2025. Trend: 2023 $3,776 · 2024 $2,607 · 2025 $3,006
Food & beverage: $2,911Education: $94
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $810 |
| Janssen Biotech, Inc. | 14 | $308 |
| GENZYME CORPORATION | 13 | $306 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $269 |
| Madrigal Pharmaceuticals | 8 | $218 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $187 |
| Gilead Sciences, Inc. | 9 | $177 |
| Ipsen Biopharmaceuticals, Inc | 8 | $168 |
| Ardelyx, Inc. | 5 | $107 |
| Regeneron Healthcare Solutions, Inc. | 3 | $85 |
Products named: DUPIXENT, TREMFYA, RINVOQ, ENTYVIO, CREON, REZDIFFRA, XIFAXAN, IQIRVO.
Industry payments across GA — which companies pay providers there.
